Prostatis Group’s Enbridge ENB Stock Holding History

Prostatis Group’s Portfolio ENB Stock Details ENB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-33,236	Closed	-$54.6K	–	136
2023 Q2	$54.6K	Buy	+33,236	New	+$1.27M	0.03%	170

Other funds holding ENB

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Prostatis Group's ENB Position: Q3 2023 in Review

Prostatis Group sold out of Enbridge (ENB) in Q3 2023, closing a stake of 33,236 shares — an estimated $54.6K sold.

Prostatis Group first reported a position in ENB in Q2 2023 and held it in 1 quarter. The position peaked at $54.6K in Q2 2023. 1,165 funds tracked by Wall St. Rank hold ENB as of Q3 2023.

Prostatis Group reported no remaining Enbridge position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 33,236 Enbridge shares in Q3 2023, an estimated $54.6K.
Prostatis Group first reported a position in Enbridge in Q2 2023 and held it in 1 quarter.
Prostatis Group's Enbridge position peaked at $54.6K in Q2 2023.
1,165 funds tracked by Wall St. Rank held Enbridge as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.